The N-acetyltransferase 10 Inhibitor [C]remodelin: Synthesis and Preliminary Positron Emission Tomography Study in Mice

Overview

Journal EJNMMI Radiopharm Chem

Date 2025 Jan 31

PMID 39888477

Authors

Rui Luo

Yiding Zhang

Katsushi Kumata

Lin Xie

Yusuke Kurihara

Masanao Ogawa

Tomomi Kokufuta

Nobuki Nengaki

Feng Wang

Ming-Rong R Zhang

Affiliations

Soon will be listed here.

Abstract

Background: 4-(4-Cyanophenyl)-2-(2-cyclopentylidenehydrazinyl)thiazole (remodelin) is a potent N-acetyltransferase 10 (NAT10) inhibitor. This compound inhibits tumors and weakens tumor resistance to antitumor drugs. Moreover, remodelin has been found to enhance healthspan in an animal model of the human accelerated ageing syndrome. In this study, we synthesized C-11-labelled remodelin ([C]remodelin) for the first time as a positron emission tomography (PET) probe and assessed its biodistribution in mice using PET.

Results: [C]Remodelin was synthesized by the reaction of a boron ester precursor (1) with hydrogen [C]cyanide, which was prepared from the cyclotron-produced [C]carbon dioxide via [C]methane. The decay-corrected radiochemical yield of [C]remodelin was 6.2 ± 2.3% (n = 20, based on [C]carbon dioxide) with a synthesis time of 45 min and radiochemical purity of > 90%. A PET study with [C]remodelin showed high uptake of radioactivity in the heart, liver, and small intestine of mice. The metabolite analysis indicated moderate metabolism of [C]remodelin in the heart.

Conclusions: In the present study, we successfully synthesized [C]remodelin and assessed its biodistribution of radioactivity in the mouse organs and tissues with PET. We are planning to prepare tumor and inflammatory models in which overexpression of NAT10 is possibly induced and conduct PET imaging for these animal models with [C]remodelin to elucidate the relationship between NAT10 and diseases.

References

Balmus G, Larrieu D, Barros A, Collins C, Abrudan M, Demir M . Targeting of NAT10 enhances healthspan in a mouse model of human accelerated aging syndrome. Nat Commun. 2018; 9(1):1700. PMC: 5923383. DOI: 10.1038/s41467-018-03770-3. View

Kawamura K, Hashimoto H, Ohkubo T, Hanyu M, Ogawa M, Nengaki N . Automated radiosynthesis of [ C]MTP38-a phosphodiesterase 7 imaging tracer-using [ C]hydrogen cyanide for clinical applications. J Labelled Comp Radiopharm. 2022; 65(5):140-146. DOI: 10.1002/jlcr.3965. View

Yui J, Hatori A, Kawamura K, Yanamoto K, Yamasaki T, Ogawa M . Visualization of early infarction in rat brain after ischemia using a translocator protein (18 kDa) PET ligand [11C]DAC with ultra-high specific activity. Neuroimage. 2010; 54(1):123-30. DOI: 10.1016/j.neuroimage.2010.08.010. View

Yu C, Chen Y, Luo H, Lin W, Lin X, Jiang Q . NAT10 promotes vascular remodelling via mRNA ac4C acetylation. Eur Heart J. 2024; 46(3):288-304. DOI: 10.1093/eurheartj/ehae707. View

Ito S, Horikawa S, Suzuki T, Kawauchi H, Tanaka Y, Suzuki T . Human NAT10 is an ATP-dependent RNA acetyltransferase responsible for N4-acetylcytidine formation in 18 S ribosomal RNA (rRNA). J Biol Chem. 2014; 289(52):35724-30. PMC: 4276842. DOI: 10.1074/jbc.C114.602698. View

Ishii H, Yamasaki T, Okamura T, Zhang Y, Kurihara Y, Ogawa M . Evaluation and improvement of CuI-mediated C-cyanation. J Labelled Comp Radiopharm. 2023; 66(3):95-107. DOI: 10.1002/jlcr.4016. View

Xue Z, Xie H, Shan Y, Zhang L, Cheng L, Chen W . NAT10 inhibition promotes ac4C-dependent ferroptosis to counteract sorafenib resistance in nasopharyngeal carcinoma. Cancer Sci. 2024; 115(10):3256-3272. PMC: 11447888. DOI: 10.1111/cas.16249. View

Jin C, Wang T, Zhang D, Yang P, Zhang C, Peng W . Acetyltransferase NAT10 regulates the Wnt/β-catenin signaling pathway to promote colorectal cancer progression via acC acetylation of KIF23 mRNA. J Exp Clin Cancer Res. 2022; 41(1):345. PMC: 9753290. DOI: 10.1186/s13046-022-02551-7. View

Zhao C, Sun X, Chen J, Geng B . NAT10-mediated mRNA N4-acetylcytidine modification of MDR1 and BCRP promotes breast cancer progression. Thorac Cancer. 2024; 15(10):820-829. PMC: 10995701. DOI: 10.1111/1759-7714.15262. View

10.

Zhang M, Kida T, Noguchi J, Furutsuka K, Maeda J, Suhara T . [(11)C]DAA1106: radiosynthesis and in vivo binding to peripheral benzodiazepine receptors in mouse brain. Nucl Med Biol. 2003; 30(5):513-9. DOI: 10.1016/s0969-8051(03)00016-7. View

11.

Larrieu D, Britton S, Demir M, Rodriguez R, Jackson S . Chemical inhibition of NAT10 corrects defects of laminopathic cells. Science. 2014; 344(6183):527-32. PMC: 4246063. DOI: 10.1126/science.1252651. View

12.

Xie R, Cheng L, Huang M, Huang L, Chen Z, Zhang Q . NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer. Cancer Res. 2023; 83(10):1666-1683. DOI: 10.1158/0008-5472.CAN-22-2233. View

13.

Cao Y, Yao M, Wu Y, Ma N, Liu H, Zhang B . N-Acetyltransferase 10 Promotes Micronuclei Formation to Activate the Senescence-Associated Secretory Phenotype Machinery in Colorectal Cancer Cells. Transl Oncol. 2020; 13(8):100783. PMC: 7232111. DOI: 10.1016/j.tranon.2020.100783. View

14.

Dalhat M, Razeeth Shait Mohammed M, Ahmad A, Imran Khan M, Choudhry H . Remodelin, a N-acetyltransferase 10 (NAT10) inhibitor, alters mitochondrial lipid metabolism in cancer cells. J Cell Biochem. 2021; 122(12):1936-1945. DOI: 10.1002/jcb.30155. View

15.

Wu Y, Cao Y, Liu H, Yao M, Ma N, Zhang B . Remodelin, an inhibitor of NAT10, could suppress hypoxia-induced or constitutional expression of HIFs in cells. Mol Cell Biochem. 2020; 472(1-2):19-31. DOI: 10.1007/s11010-020-03776-w. View

16.

Wei R, Cui X, Min J, Lin Z, Zhou Y, Guo M . NAT10 promotes cell proliferation by acetylating mRNA to enhance translation efficiency in multiple myeloma. Acta Pharm Sin B. 2022; 12(8):3313-3325. PMC: 9366180. DOI: 10.1016/j.apsb.2022.01.015. View

17.

Ma N, Liu H, Wu Y, Yao M, Zhang B . Inhibition of -Acetyltransferase 10 Suppresses the Progression of Prostate Cancer through Regulation of DNA Replication. Int J Mol Sci. 2022; 23(12). PMC: 9223896. DOI: 10.3390/ijms23126573. View

18.

Obokata N, Seki C, Hirata T, Maeda J, Ishii H, Nagai Y . Synthesis and preclinical evaluation of [C]MTP38 as a novel PET ligand for phosphodiesterase 7 in the brain. Eur J Nucl Med Mol Imaging. 2021; 48(10):3101-3112. PMC: 8426238. DOI: 10.1007/s00259-021-05269-4. View

19.

Wu J, Zhu H, Wu J, Chen W, Guan X . Inhibition of N-acetyltransferase 10 using remodelin attenuates doxorubicin resistance by reversing the epithelial-mesenchymal transition in breast cancer. Am J Transl Res. 2018; 10(1):256-264. PMC: 5801363. View

20.

Hu K, Xie L, Zhang Y, Hanyu M, Yang Z, Nagatsu K . Marriage of black phosphorus and Cu as effective photothermal agents for PET-guided combination cancer therapy. Nat Commun. 2020; 11(1):2778. PMC: 7280494. DOI: 10.1038/s41467-020-16513-0. View